NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
ID: 347883Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347883

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-020.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled the NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program, aimed at enhancing the rigor and transparency of neuroscience research within academic institutions. This initiative seeks to establish innovative programs at various intra-institutional levels to promote high-quality research practices, addressing issues such as bias and methodological rigor in scientific studies. The NIH plans to allocate approximately $3.5 million annually for at least five awards, with individual budgets typically ranging from $150,000 to $800,000 per year and a maximum project duration of three years. Interested applicants, including higher education institutions and various nonprofit and government entities, must submit their applications by October 17, 2025, and can find further details and submission instructions at the provided NIH link or by contacting grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-NS-24-020-Full-Announcement.html
    RFA-NS-24-020.html
    The National Institutes of Health (NIH) is offering a funding opportunity titled NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) to enhance the rigor and transparency of neuroscience research within academic institutions. This program is focused on creating innovative programs at various intra-institutional levels to promote high-quality research practices that address issues such as bias in the scientific process and lack of rigorous methodologies. The NIH intends to allocate approximately $3.5 million annually for at least five awards, with budgets typically ranging from $150,000 to $800,000 per year and a maximum project duration of three years. Eligible applicants include higher education institutions and various nonprofit and government entities involved in neuroscience research relevant to the NINDS mission. The application deadlines begin on September 17, 2023, with extensive instructions on submission details and program requirements. This funding initiative aims to foster a culture of rigorous research and accountability, encouraging institutions to adopt and disseminate best practices within the broader scientific community, ultimately improving the integrity and value of scientific findings in neuroscience.
    Similar Opportunities
    NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program, a federal grant opportunity aimed at enhancing research rigor and transparency within academic and research institutions in the field of neuroscience. This initiative seeks to implement innovative programs that promote rigorous study design and transparent reporting, ultimately fostering a culture of high-quality research practices. Grants ranging from $150,000 to $800,000 are available, with a total funding pool of $3.5 million anticipated for at least five awards annually. Applications are due by October 17, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries or visit the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-020.html for more details.
    NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), has announced a funding opportunity titled "NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)" aimed at enhancing research education in biomedical, behavioral, and clinical research. This initiative seeks applications for innovative educational activities that provide hands-on research experiences and skills development, particularly in the field of neuroscience, with a maximum funding of $250,000 per year for up to five years. The program emphasizes diversity recruitment and significant institutional commitment, requiring applicants to include a comprehensive evaluation plan and adhere to strict guidelines. Interested parties can find more information and apply by July 14, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the STrengthening Research Opportunities for NIH Grants (STRONG) program, which focuses on conducting structured institutional needs assessments and developing action plans for Resource Limited Institutions (RLIs). The initiative aims to enhance the research capacity of RLIs, which serve historically underrepresented populations in biomedical research and have received NIH support of $0 to $25 million annually over the past three fiscal years. This program is crucial for improving competitiveness for NIH funding and fostering research career development in diverse environments. Eligible institutions can apply for a maximum budget of $250,000 annually for a project period of three years, with applications due by September 18, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR Program), aimed at enhancing the participation of individuals from diverse backgrounds in neuroscience research. This grant opportunity supports eligible domestic institutions in developing educational initiatives that include skills development and hands-on research experiences, specifically targeting postbaccalaureate participants from institutions with limited research opportunities. The program is critical for fostering a diverse biomedical research workforce and facilitating entry into rigorous doctoral programs in neuroscience, with funding anticipated to range from $1 million to $1.35 million for awards in FY 2026. Applications are due by March 26, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)" aimed at fostering a diverse research workforce in neuroscience. This initiative encourages applications from organizations proposing innovative mentoring and professional development activities to support individuals from underrepresented backgrounds in neuroscience research, focusing on enhancing retention and career advancement across various stages. The program is particularly significant for promoting diversity within the scientific workforce, which is essential for enhancing the quality and innovation potential of research. Interested applicants can apply for grants of up to $250,000 annually for a maximum of five years, with the application deadline set for September 26, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-178.html.
    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)." This initiative aims to support the characterization and efficacy studies of neurotherapeutic agents intended for treating neurological disorders, with a focus on conducting pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate the biological activity of proposed therapeutic agents. The program emphasizes the importance of rigorous experimental design, collaboration, and the inclusion of diverse perspectives in research teams, aligning with NIH's mission to translate research discoveries into effective therapies. Interested applicants can apply for funding up to $499,000 per year for a total project duration not exceeding three years, with the application deadline set for October 20, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-225.html.
    NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for the Biobehavioral Research Awards for Innovative New Scientists (BRAINS), aimed at supporting early-stage investigators in launching innovative research focused on mental disorders. This program seeks to fund high-risk, high-reward projects that may not have the preliminary data typically required for traditional funding, with an emphasis on advancing understanding and treatment of mental health issues. Eligible applicants include tenure-track faculty designated as Early Stage Investigators by NIH, and the grant provides up to $500,000 per year for a maximum of five years, with a total of approximately $3 million allocated annually for 6-8 awards. Interested parties can find more information and apply by June 20, 2025, and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) to support innovative and exploratory research projects in neuroscience. This grant aims to facilitate early-stage studies that assess novel avenues of investigation, particularly those that may involve significant risk but hold the potential for breakthroughs in understanding neuroscience or developing new methodologies. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and tribal governments, with funding available up to $200,000 over two years. Interested parties should submit their applications by January 7, 2025, and can find additional information and application guidelines at the NIH website or contact grantsinfo@nih.gov for assistance.
    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Innovation Grants to Nurture Initial Translational Efforts (IGNITE) funding opportunity, aimed at supporting pharmacodynamic, pharmacokinetic, and in vivo efficacy studies of therapeutic agents for neurological and neuromuscular disorders. This grant follows the R61/R33 phased award mechanism, where the R61 phase focuses on preparation and characterization, while the R33 phase emphasizes efficacy studies, with a critical transition contingent upon meeting specific milestones. The program encourages collaboration among various organizations, including nonprofit entities and academic institutions, to accelerate the development of promising therapies, with awards capped at $750,000 over a maximum project duration of three years. Interested applicants can find more information and application instructions at the NIH grants website, and the deadline for submissions is October 20, 2027.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity" (PAR-22-181), aimed at enhancing the diversity of the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program emphasizes the importance of addressing health disparities and promoting diverse representation in science, with funding allocations of up to $10 million for NINDS and $5 million for NIDA/NIMH, among others, for a maximum project period of five years. Interested applicants should submit their proposals by June 6, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.